Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nutra PharmaNPHC Days Inventory is 84.80 as of Jun. 2026, which is 31% above its 10-year median of 64.80. The stock has 5 warning signs investors should review. Among 921 Drug Manufacturers companies, Nutra Pharma ranks better than 94.57% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Nutra Pharma's Average Total Inventories for the
three
months ended in Jun. 2026 was $0.02 Mil. Nutra Pharma's Cost of Goods Sold for the
three
months ended in Jun. 2026 was $0.03 Mil.
Hence, Nutra Pharma's Days Inventory for the
three
months ended in Jun. 2026 was 84.80.
The historical rank and industry rank for Nutra Pharma's Days Inventory or its related term are showing as below:
NPHC'
s Days Inventory Range Over the Past 10 Years
Min: 36.89 Med: 64.8 Max: 310.93
Current: 48.35
During the past 13 years, Nutra Pharma's highest Days Inventory was 310.93. The lowest was 36.89. And the median was 64.80.
NPHC's Days Inventory is ranked better than 94.57% of 921
companies
in the Drug Manufacturers industry
Industry Median: 165.34
vs NPHC: 48.35
Nutra Pharma's Days Inventory
increased
from Jun. 2025 (32.59) to Jun. 2026 (84.80).
It might indicate that Nutra Pharma's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Nutra Pharma's Inventory Turnover for the
three
months ended in Jun. 2026 was 1.08.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nutra Pharma's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.41.
Nutra Pharma (OTCPK:NPHC) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Nutra Pharma's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nutra Pharma's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Nutra Pharma Days Inventory Related Terms
Nutra Pharma Days Inventory Historical Data
* Premium members only.
The historical data trend for Nutra Pharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NPHC vs CBDY, SKYI, STEK: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Nutra Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nutra Pharma Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nutra Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where Nutra Pharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nutra Pharma (NPHC) has a Days Inventory of 84.80 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Nutra Pharma and its competitors. This is 31% above median its historical median of 64.80. Over the past decade, Nutra Pharma's Days Inventory has ranged from 36.89 to 310.93. According to the industry distribution chart, Nutra Pharma ranks #50 out of 921 companies in the Drug Manufacturers industry, placing it in the top 5.4%.
Is Nutra Pharma's Days Inventory too high?
Nutra Pharma's current Days Inventory of 84.80 is 31% above median its 10-year median of 64.80. Over the past 10 years, this metric has ranged from a low of 36.89 to a high of 310.93. The Drug Manufacturers industry median Days Inventory is 165.34. Nutra Pharma's value of 84.80 is 48.7% below this industry median. Based on the distribution chart, Nutra Pharma ranks #50 out of 921 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Nutra Pharma's Days Inventory compare to CBDY and SKYI?
According to the Drug Manufacturers industry distribution chart, Nutra Pharma ranks #50 out of 921 companies for Days Inventory. This places Nutra Pharma in the top 5% of its industry — outperforming the majority of peers. The industry median Days Inventory is 165.34. Nutra Pharma's value of 84.80 is 48.7% below this benchmark. Historically, Nutra Pharma's own Days Inventory has ranged from 36.89 to 310.93 over the past decade. While the company's 10-year median is 64.80 vs. the industry median of 165.34, Nutra Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.34, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nutra Pharma's current Days Inventory of 84.80 is 48.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Nutra Pharma and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nutra Pharma's current Days Inventory is 84.80, which is 31% above median its own 10-year median of 64.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutra Pharma stock overvalued right now?
Nutra Pharma (NPHC) has a current Days Inventory of 84.80. The current Days Inventory is 84.80, which is 31% above median its 10-year median of 64.80 and 48.7% below the Drug Manufacturers industry median of 165.34. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Nutra Pharma (NPHC), the current Days Inventory is 84.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nutra Pharma Corp operates as a biopharmaceutical company with intellectual property for drugs that treat autoimmune disorders, viral diseases, and pain. It is focused on homeopathic and drug discovery research and clinical development, and has developed four homeopathic drugs for the relief of pain: Nyloxin and Nyloxin Extra Strength, Pet Pain-Away, Equine Pain-Away, and Luxury Feet. Additionally, the company has developed two drug candidates: RPI-78M, to treat neurological diseases and autoimmune diseases; and RPI-MN, to treat viral diseases, including HIV/AIDS and Herpes. Nutra Pharma produces, markets, and distributes its branded products both domestically and internationally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NPHC has been successfully added to your 
